{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:11:07Z","timestamp":1649149867809},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41443-018-0040-8","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T20:17:10Z","timestamp":1538165830000},"page":"300-300","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cPatient perspectives on Peyronie\u2019s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum\u201d"],"prefix":"10.1038","volume":"31","author":[{"given":"Faysal A.","family":"Yafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","unstructured":"Kaminetsky J, Gittleman M, Kaufman GJ, Smith TM, Jordan GH. Patient perspectives on Peyronie\u2019s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum. IJIR. 2018.","DOI":"10.1038\/s41443-018-0027-5"},{"key":"40_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.urology.2017.05.029","volume":"107","author":"EC Serefoglu","year":"2017","unstructured":"Serefoglu EC, Smith TM, Kaufman GJ, Liu G, Yafi FA, Hellstrom WJG. Factors associated with erectile dysfunction and the peyronie\u2019s disease questionnaire in patients with Peyronie disease. Urology. 2017;107:155\u201360.","journal-title":"Urology"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/andr.12302","volume":"5","author":"J Anaissie","year":"2017","unstructured":"Anaissie J, Yafi FA, Traore EJ, Sikka SC, Hellstrom WJ. Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie\u2019s disease. Andrology. 2017;5:274\u20137.","journal-title":"Andrology"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, Jones N, Kaufman GJ, Carson CC 3rd. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.urology.2016.09.050","volume":"100","author":"J Anaissie","year":"2017","unstructured":"Anaissie J, Yafi FA, DeLay KJ, Traore EJ, Sikka SC, Hellstrom WJG. Impact of number of cycles of collagenase clostridium histolyticum on outcomes in patients with Peyronie\u2019s disease. Urology. 2017;100:125\u201330.","journal-title":"Urology"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0040-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:40:48Z","timestamp":1648658448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0040-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0040-8","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}